Using a double-blinded, placebo-controlled design, 12 months of daily T gel treatment increased Hb levels by at least 1.0 g/dL in ~52% of more men with hypogonadism and a known cause of anemia when compared with placebo. The gene discussed is GSTM1; the disease is anemia.